Assertio holdings, inc. signs exclusive license for sympazan® (clobazam) oral film from aquestive therapeutics, inc.

Trailing 12 month revenues of sympazan were $9.5 million assertio paid $9.0 million upfront, additional $6.0 million upon patent allowance
ASRT Ratings Summary
ASRT Quant Ranking